Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Synovial Telocytes are Characterized by Efhd1, Dpp4, and Pi16 Expression, Show High Responsiveness to Osmotic Stress, and Exhibit Fibroblast Plasticity Potential.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same author

A RANKL<sup>+</sup>/CXCR4<sup>+</sup> B cell population accumulates in bone marrow and causes age-related osteoporosis in mice.

Bone research·2026

Same author

Lymphatic Vessels are Involved in Monosodium Urate Clearance and Resolution of Gouty Inflammation in Mice.

Journal of inflammation research·2026

Same author

Telocyte Deletion Associated With Loss of Lymphatic Drainage and Exacerbation of Inflammatory-Erosive Arthritis in Mice.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same author

Lymph nodes-targeted nano-prodrug for precise B cell immunoregulation to prevent collagen-induced arthritis.

Biomaterials·2026

Same author

The Function of <i>Efhd1</i> <sup>+</sup> Telocytes in the Synovial Lymphatic System and Inflammatory-Erosive Arthritis.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

SRC inhibitors in metastatic bone disease.

Brendan F Boyce¹, Lianping Xing, Zhenqiang Yao

¹University of Rochester Medical Center, Rochester, New York 14642, USA. brendan_boyce@urmc.rochester.edu

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

|October 26, 2006

Summary

Src tyrosine kinase plays a key role in bone resorption. Inhibitors targeting this enzyme offer a promising new approach for treating bone loss diseases like osteoporosis, potentially improving upon current therapies.

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Models of Bone Metastasis

Models of Bone Metastasis

Published on: September 4, 2012

Related Experiment Videos

Last Updated: Jul 19, 2026

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Models of Bone Metastasis

Models of Bone Metastasis

Published on: September 4, 2012

Area of Science:

Bone biology and molecular signaling
Pharmacology of bone resorption inhibitors

Background:

Src tyrosine kinase was the first identified gene critical for bone function.
Osteoclast regulation is key to understanding bone catabolism, with genetic studies in mice and humans revealing crucial enzymes.
Bisphosphonates are effective for bone loss but have limitations in patient compliance due to side effects and administration requirements.

Purpose of the Study:

To review current understanding of signaling pathways regulating osteoclast function.
To highlight the role of Src tyrosine kinase in bone catabolism.
To discuss the effects of Src kinase inhibitors in models of increased bone resorption.

Main Methods:

Review of existing literature on Src tyrosine kinase and osteoclast biology.
Analysis of genetic knockout studies in mice and human mutation data.
Evaluation of Src kinase inhibitors in preclinical models of bone resorption.

Main Results:

Src tyrosine kinase is essential for osteoclast formation, activation, and survival.
Inhibitors targeting Src kinase have shown promise as therapeutic agents for bone loss.
Targeting Src inhibitors to bone may limit systemic side effects.

Conclusions:

Src tyrosine kinase is a critical regulator of bone resorption.
Src kinase inhibitors represent a potential new class of drugs for osteoporosis and metastatic bone disease.
Targeted delivery of Src inhibitors could enhance therapeutic efficacy and safety.